Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus

被引:44
|
作者
Baltch, Aldona L. [1 ]
Ritz, William J.
Bopp, Lawrence H.
Michelsen, Phyllis B.
Smith, Raymond P.
机构
[1] Stratton VA Med Ctr, Infect Dis Sect 111D, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
关键词
D O I
10.1128/AAC.00973-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We investigated the anti staphylococcal activity of daptomycin, vancomycin, oxacillin, gentamicin, and rifampin in human monocyte-derived macrophages. Compared with vancomycin and oxacillin, daptomycin had the most rapid and greatest antibacterial activity, but that of oxacillin was most sustained. The combination of daptomycin, gentamicin, and rifampin was most effective intracellularly, while daptomycin plus gentamicin and the three-drug combination were most effective extracellularly, completely eliminating viable Staphylocorcus aureus.
引用
收藏
页码:1559 / 1562
页数:4
相关论文
共 50 条
  • [1] Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
    LaPlante, Kerry L.
    Woodmansee, Suzanne
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3880 - 3886
  • [2] Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
    Jiang, Jhih-Hang
    Peleg, Anton Y.
    GENES, 2015, 6 (04) : 1256 - 1267
  • [3] Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology
    Credito, Kim
    Lin, Gengrong
    Appelbaum, Peter C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1504 - 1507
  • [4] Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
    Leonard, Steven N.
    Rolek, Kiri M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 644 - 647
  • [5] In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
    Akins, RL
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1925 - 1929
  • [6] Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin
    Melard, Aurelie
    Garcia, Laetitia G.
    Das, Debaditya
    Rozenberg, Raoul
    Tulkens, Paul M.
    Van Bambeke, Francoise
    Lemaire, Sandrine
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 648 - 658
  • [7] INVITRO EVALUATION OF CLINDAMYCIN IN COMBINATION WITH OXACILLIN, RIFAMPIN, OR VANCOMYCIN AGAINST STAPHYLOCOCCUS-AUREUS
    HO, JL
    KLEMPNER, MS
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 4 (02) : 133 - 138
  • [8] In Vitro Activity of Daptomycin in Combination with β-Lactams, Gentamicin, Rifampin, and Tigecycline against Daptomycin-Nonsusceptible Enterococci
    Hindler, Janet A.
    Wong-Beringer, Annie
    Charlton, Carmen L.
    Miller, Shelley A.
    Kelesidis, Theodoros
    Carvalho, Marissa
    Sakoulas, George
    Nonejuie, Poochit
    Pogliano, Joseph
    Nizet, Victor
    Humphries, Romney
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4279 - 4288
  • [9] In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
    Tong, Jiepeng
    Jiang, Yiheng
    Xu, Hao
    Jin, Xuehang
    Zhang, Li
    Ying, Shuaibing
    Yu, Wei
    Qiu, Yunqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3049 - 3055
  • [10] Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin
    Brinch, Karoline Sidelmann
    Tulkens, Paul M.
    Van Bambeke, Francoise
    Frimodt-Moller, Niels
    Hoiby, Niels
    Kristensen, Hans-Henrik
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (08) : 1720 - 1724